Related Experiment Video
Updated: Apr 21, 2026
03:37
Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
Published on: October 11, 2024
912
Docetaxel inhibits urethral stricture formation, an initial study in rabbit model
Delai Fu1, Tie Chong1, Hecheng Li1
1Department of Urology, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.
Plos One
|November 7, 2014
Summary
Docetaxel effectively limited urethral stricture formation in rabbits by reducing fibrous tissue and collagen. This finding suggests docetaxel as a potential new treatment for preventing urethral stricture in men.
Area of Science:
- Urology
- Pharmacology
Background:
- Urethral stricture is a common cause of lower urinary tract disorders in men.
- Docetaxel, a paclitaxel analogue, was investigated for its anti-stricture potential based on paclitaxel's anti-restenosis effects.
Purpose of the Study:
- To evaluate the efficacy of docetaxel in preventing urethral stricture formation.
- To assess the impact of docetaxel on urethral diameter and lumen reduction post-injury.
Main Methods:
- A rabbit model of induced urethral stricture was used.
- Animals were divided into high-dose docetaxel, low-dose docetaxel, and control groups.
- Docetaxel was administered via daily urethral irrigation for 28 days.
Main Results:
- Docetaxel treatment significantly increased urethral diameter and reduced lumen reduction compared to controls.
- Histological analysis revealed decreased fibrous tissue and collagen in docetaxel-treated groups.
- Significant differences in urethral diameter and lumen reduction were observed between docetaxel groups and the control group.
Conclusions:
- Docetaxel demonstrates a significant inhibitory effect on urethral stricture formation.
- The mechanism may involve the suppression of fibrous tissue and collagen expression.
- Docetaxel presents a promising new therapeutic option for preventing urethral stricture.
